Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 189

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1
Chunk 189
---
 liquidity risk and concerns. Although the Department of the Treasury, the Federal Reserve, and the FDIC jointly confirmed
that depositors at SVB and Signature Bank would continue to have access to their funds, even those in excess of the standard FDIC insurance
limits, under a systemic risk exception, future adverse developments with respect to specific financial institutions or the broader financial
services industry may lead to market-wide liquidity shortages, impair the ability of companies to access near-term working capital needs,
and create additional market and economic uncertainty. There can be no assurance that future credit and financial market instability
and a deterioration in confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any
such economic downturn, liquidity shortages, volatile business environment or continued unpredictable and unstable market conditions.
If the equity and credit markets deteriorate, or if adverse developments are experienced by financial institutions, it may cause short-term
liquidity risk and also make any necessary debt or equity financing more difficult, more costly and more dilutive. Failure to secure
any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial
performance and stock price and could require us to delay or abandon our business plans. In addition, there is a risk that one or more
of our current clients, financial institutions or other third parties with whom we do business may be adversely affected by the foregoing
risks, which may have an adverse effect on our business.

The
dual-class structure of our common stock as contained in our Certificate of Incorporation has the effect of concentrating voting control
with those stockholders who held our Class B common stock. This ownership will limit or preclude your ability to influence corporate
matters, including the election of directors, amendments of our organizational documents, and any merger, consolidation, sale of all
or substantially all of our assets, or other major corporate transactions requiring stockholder approval, and that may adversely affect
the trading price of our Class A common stock.

Our
Class B common stock has 16.5 votes per share, and our Class A common stock has one vote per share. As of December 31, 2024, there were
833,334 shares of our Class B common stock outstanding, representing 79.6% of our total voting securities outstanding. Holders of all
of the issued and outstanding shares of our Class B common stock own 833,334 shares of Class B common stock representing approximately
60.5% of the voting power